Allogene Therapeutics, a biotech company developing allogeneic CAR T therapies for cancer and autoimmune diseases, announced its participation in three upcoming investor conferences in November and December 2026. These events include the UBS Global Biopharma Conference, Jefferies Global Healthcare Conference, and Piper Sandler Healthcare Conference. The company will provide live webcasts and replays on its website, offering investors updates on its progress and pipeline. This engagement highlights Allogene's efforts to keep investors informed as it advances its off-the-shelf CAR T cell therapy products.
Allogene Therapeutics' upcoming investor conferences provide context for readers interested in biotech developments. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 26, 2026 19:02 WIB: Of 150 priced health-sector US stocks tradable on Pluang, 78 rose and 48 fell today. Notable movers include VTRS at USD 18.44 (+2.44%), WGS at USD 57.50 (+2.40%), and NVS at USD 153.99 (+1.90%).
Senseonics Holdings has begun the first human clinical trial of Freedom, a next-generation continuous glucose monitoring (CGM) system designed without an external on-body transmitter. This implantable device communicates directly with mobile devices ...
Stryker Corporation has finalized its acquisition of ZuriMED, incorporating the FiberLocker System into its Sports Medicine offerings. This technology enhances rotator cuff repair by improving biomechanical strength, addressing a key clinical need. T...
Kratos Defense & Security Solutions announced it will release its third quarter 2026 financial results after market close on November 5, 2026. The company will hold a conference call at 2:00 p.m. Pacific Time to discuss its operations and financial p...
FOREWARN, a safety solutions provider for real estate professionals, introduced Community Alerts, a new feature that allows agents to flag phone numbers after concerning interactions. This alert is instantly shared across its network of over 443,000 ...
Franklin Electric Co., Inc. announced a quarterly cash dividend of $0.28 per share, payable on November 19, 2026, to shareholders of record as of November 5, 2026. This dividend reflects the company's ongoing commitment to returning value to its shar...
